Patients with multiple myeloma suffer from a malignant proliferation of plasma cells in their bone marrow The standard treatment for this form of cancer is high-dose chemotherapy and transplantation of one’s own blood-producing adult stem cells  however  this aggressive treatment wipes out the mature immune-system cells of patients – leaving them vulnerable to infection